BI 224436
CAS No. 1155419-89-8
BI 224436 ( BI224436 )
Catalog No. M10545 CAS No. 1155419-89-8
BI 224436 is a potent, specific, noncatalytic site integrase inhibitor (NCINI) of HIV-1 with EC50 of 11-27 nM against different HIV-1 laboratory strains.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 312 | Get Quote |
|
50MG | 1341 | Get Quote |
|
100MG | 1791 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBI 224436
-
NoteResearch use only, not for human use.
-
Brief DescriptionBI 224436 is a potent, specific, noncatalytic site integrase inhibitor (NCINI) of HIV-1 with EC50 of 11-27 nM against different HIV-1 laboratory strains.
-
DescriptionBI 224436 is a potent, specific, noncatalytic site integrase inhibitor (NCINI) of HIV-1 with EC50 of 11-27 nM against different HIV-1 laboratory strains, with minimal cellular cytotoxicity; exhibits a low, ~2.1-fold decrease in antiviral potency in the presence of 50% human serum andserum-shifted EC95 values ranging between 22 and 75 nM; also retains full antiviral activity against recombinant viruses encoding INSTI resistance substitutions N155S, Q148H, and E92Q; displays an additive effect in combination with most approved antiretrovirals, including INSTIs.HIV Infection Phase 1 Clinical
-
SynonymsBI224436
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research AreaInfection
-
IndicationHIV Infection
Chemical Information
-
CAS Number1155419-89-8
-
Formula Weight391.47
-
Molecular FormulaC24H25NO4
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 50 mg/mL 112.99 mM
-
SMILESO=C(O)[C@H](C1=C(C2=CC(CCCO3)=C3C=C2)C4=CC=CC=C4N=C1)OC(C)(C)C
-
Chemical Name(2S)-[4-(3,4-Dihydro-2H-chromen-6-yl)-3-quinolinyl][(2-methyl-2-propanyl)oxy]acetic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Fader LD, et al. ACS Med Chem Lett. 2014 Jan 22;5(4):422-7.
2. Fenwick C, et al. Antimicrob Agents Chemother. 2014 Jun;58(6):3233-44.
3. Demeulemeester J, et al. Expert Opin Ther Pat. 2014 Jun;24(6):609-32.
2. Fenwick C, et al. Antimicrob Agents Chemother. 2014 Jun;58(6):3233-44.
3. Demeulemeester J, et al. Expert Opin Ther Pat. 2014 Jun;24(6):609-32.
molnova catalog
related products
-
DRB
DRB is a nucleoside analog that inhibits several carboxyl-terminal domain (CTD) kinases including casein kinase II (IC50 range of 4-10 μM).
-
Doravirine
Doravirine (MK-1439, MK1439) is a novel, highly specific HIV-1 nonnucleoside reverse transcriptase inhibitor (NNRTI) with IC50 of 12, 9.7, and 9.7 nM against WT, K103N, and Y181C reverse transcriptase (RT) mutants, respectively.
-
DDX3-IN-16d
A small molecule inhibitor (IC50=0.3 uM) of DEAD-box polypeptide 3 (DDX3).